Read + Share
Amedeo Smart
Independent Medical Education
Rosenzwajg M, Gherasim A, Dietsch F, Beck M, et al. Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial. J Allergy Clin Immunol 2024 Nov 10:S0091-6749(24)01181.PMID: 39532189
Email
LinkedIn
Privacy Policy